Singapore, Singapore

Padmanabhan Parasuraman

This inventor holds 1 USPTO granted patent. Top assignee: Agency for Science, Technology and Research. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Padmanabhan Parasuraman. Retrieved from https://idiyas.com/inventor/padmanabhan-parasuraman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Padmanabhan Parasuraman and Cell-Targeting Nanoparticle Innovation.

Introduction

Padmanabhan Parasuraman is an inventor based in Singapore and associated with the Agency for Science, Technology and Research. His patent work concerns nanoparticle technology designed to target cells and support potential biomedical applications.

Latest Patents

Parasuraman is named on 1 patent: “Cell-Targeting Nanoparticles and Uses Thereof.” The invention describes a cell-targeting nanoparticle directly conjugated to at least one cysteine-containing peptide. The specified peptides include glutathione, a glutathione-containing peptide, and a peptide comprising a nuclear localization signal sequence and a transporter sequence. The patent also addresses methods for using these nanoparticles.

Career Highlights

The available information identifies Parasuraman’s work with the Agency for Science, Technology and Research and his contribution to research on peptide-conjugated nanoparticles. The invention focuses on combining nanoparticle targeting with peptide components that may support cellular delivery.

Collaborations

The listed collaborators include Tamil Selvan Subramanian and Dominik Janczewski. Their names are associated with the patent work on cell-targeting nanoparticles.

Conclusion

Padmanabhan Parasuraman’s patent reflects research into peptide-functionalized nanoparticles and their potential uses, highlighting his contribution to biomedical innovation in Singapore.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…